Entera Bio (ENTX) News Today $1.88 +0.08 (+4.44%) As of 02:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Entera Bio (ENTX) Projected to Post Earnings on FridayAugust 1, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Up 10.8% - What's Next?July 29, 2025 | marketbeat.comEntera Bio stock surges after FDA agrees on BMD endpoint for EB613July 28, 2025 | investing.comEntera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with OsteoporosisJuly 28, 2025 | globenewswire.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest UpdateJune 15, 2025 | marketbeat.comEntera Bio Stock Price, Quotes and Forecasts | NASDAQ:ENTX | BenzingaJune 6, 2025 | benzinga.comNorthern Trust Corp Acquires New Position in Entera Bio Ltd. (NASDAQ:ENTX)June 1, 2025 | marketbeat.comKnoll Capital Management LLC Grows Holdings in Entera Bio Ltd. (NASDAQ:ENTX)May 23, 2025 | marketbeat.comEntera Bio Reports Q1 2025 Financial Results and Strategic DevelopmentsMay 16, 2025 | tipranks.comEntera Bio (NASDAQ:ENTX) Announces Quarterly Earnings ResultsMay 12, 2025 | marketbeat.comEntera Bio Ltd.: Entera Bio Announces First Quarter 2025 Financial Results and Business UpdatesMay 10, 2025 | finanznachrichten.deEntera Bio Announces First Quarter 2025 Financial Results and Business UpdatesMay 9, 2025 | globenewswire.comEntera Bio (ENTX) to Release Earnings on FridayMay 4, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Up 5.6% - Time to Buy?April 26, 2025 | marketbeat.comEntera Bio announces highlights from presentation at WCO-IFO-ESCEO on EB613April 15, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 13.7%April 4, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Issues Earnings ResultsMarch 29, 2025 | marketbeat.comEntera Bio Reports Transformative Year in 2024March 28, 2025 | tipranks.comEntera Bio Announces Full Year 2024 Financial Results and Provides Business UpdatesMarch 28, 2025 | globenewswire.comEntera Bio Ltd.March 26, 2025 | wsj.comEntera Bio's (ENTX) "Buy" Rating Reiterated at HC WainwrightMarch 19, 2025 | marketbeat.comOpko Health, Entera Bio to Collaborate on Tablet for Obesity, Metabolic and Fibrotic DisordersMarch 17, 2025 | marketwatch.comOpko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptideMarch 17, 2025 | markets.businessinsider.comOpko Health, Entera Bio enter into collaboration agreementMarch 17, 2025 | markets.businessinsider.comEntera Bio Collaborates with OPKO for Oral GLP-1/GlucagonMarch 17, 2025 | tipranks.comOPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic DisordersMarch 17, 2025 | globenewswire.comEntera Bio (ENTX) Expected to Announce Quarterly Earnings on FridayMarch 7, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Down 1.4% - Time to Sell?February 25, 2025 | marketbeat.comEntera Bio to Participate in Upcoming EventsFebruary 24, 2025 | globenewswire.comEntera Bio announces acceptance of EB613 abstracts for WCO-IOF-ESCEOFebruary 19, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 31.6%February 15, 2025 | marketbeat.comIs Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?February 6, 2025 | uk.finance.yahoo.comPerigon Wealth Management LLC Takes $325,000 Position in Entera Bio Ltd. (NASDAQ:ENTX)February 3, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Growth in Short InterestJanuary 31, 2025 | marketbeat.comEntera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceJanuary 27, 2025 | globenewswire.comEntera Bio (NASDAQ:ENTX) Stock Price Up 1.1% - Still a Buy?January 7, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short InterestDecember 1, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Large Increase in Short InterestNovember 17, 2024 | marketbeat.comHC Wainwright Decreases Earnings Estimates for Entera BioNovember 14, 2024 | marketbeat.comEntera Bio Buy Rating: Strong Financials, Strategic Developments, and Promising Pipeline Drive Analyst ConfidenceNovember 12, 2024 | markets.businessinsider.comEntera Bio's (ENTX) "Buy" Rating Reaffirmed at HC WainwrightNovember 11, 2024 | marketbeat.comEntera Bio Highlights Q3 2024 Financials and FDA AnticipationNovember 9, 2024 | markets.businessinsider.comEntera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNovember 8, 2024 | globenewswire.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 14.4% in OctoberOctober 29, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in SeptemberOctober 13, 2024 | marketbeat.comBuy Rating Affirmed for Entera Bio’s EB613: A Game Changer in Osteoporosis TreatmentOctober 7, 2024 | markets.businessinsider.comEntera Bio (NASDAQ:ENTX) Earns "Buy" Rating from HC WainwrightOctober 7, 2024 | marketbeat.comEntera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersSeptember 25, 2024 | globenewswire.comQuantum Genomics Société Anonyme (2QG.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comWe're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn RateAugust 30, 2024 | finance.yahoo.com Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address ENTX Media Mentions By Week ENTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENTX News Sentiment▼0.000.37▲Average Medical News Sentiment ENTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENTX Articles This Week▼01▲ENTX Articles Average Week Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Humacyte News Today Kodiak Sciences News Today Aura Biosciences News Today Arcturus Therapeutics News Today Abeona Therapeutics News Today Nanobiotix News Today Cartesian Therapeutics News Today Rocket Pharmaceuticals News Today Candel Therapeutics News Today Amarin News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENTX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
